Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Credit agrmnt [a]
Acq. announced
Consulting agrmnt
Quarterly results
|
|
Horizon Therapeutics Public Ltd Co (HZNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/19/2014 |
8-K
| Director compensation was amended/approved, Acquisition/merger/asset purchase announced, Entered into consulting agreement|
Docs:
|
"Memorandum and Articles of Association of Horizon Pharma Public Limited Company",
"First Supplemental Indenture, by and among Horizon Pharma, Inc., Horizon Pharma Public Limited Company and U.S Bank National Association",
"Form of Indemnification Agreement entered into by and between Horizon Pharma Public Limited Company and certain of its directors, officers and employees",
"Form of Indemnification Agreement entered into by and between Horizon Pharma, Inc. and certain directors, officers and employees of Horizon Pharma Public Limited Company",
"Temporary Escrow Agreement, by and among Vidara Therapeutics Holdings LLC, Horizon Pharma, Inc. and Citibank, National Association, as escrow agent",
"Horizon Pharma Public Limited Company Non-Employee Director Compensation Policy",
"Code of Business Conduct and Ethics of Horizon Pharma Public Limited Company",
"Letter from Habif, Arogeti & Wynne LLP",
"Description of Horizon Pharma Public Limited Company Share Capital",
"Registration Rights Agreement, by and among Vidara Therapeutics International plc (now known as Horizon Pharma Public Limited Company), Vidara Therapeutics Holdings LLC and certain shareholders of Vidara Therapeutics International plc" |
|
|
|